Home>
US Stocks>
Perspective Therapeutics Inc.

Perspective Therapeutics Inc. share price today

(CATX)

Perspective Therapeutics Inc. share price is $3.76 & ₹318.43 as on 7 Dec 2024, 2.30 'hrs' IST

$3.76

▲

0.04

(1.08%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Perspective Therapeutics Inc. share price in Dollar and Rupees. Guide to invest in Perspective Therapeutics Inc. from India. Also see the sentimental analysis on Indian investors investing in Perspective Therapeutics Inc.. Get details on the Indian mutual funds that are investing in Perspective Therapeutics Inc.. Get Analyst recommendations and forecasts along with all the Perspective Therapeutics Inc.'s financials.

Perspective Therapeutics Inc. share price movements

$3.53
$3.84
$3.76
6.12%
Downside
Day's Volatility :8.07%
Upside
2.08%
$2.28
$19.05
$3.76
39.36%
Downside
52 Weeks Volatility :88.03%
Upside
80.26%

Perspective Therapeutics Inc. Returns

Period	Perspective Therapeutics Inc.	Index (Russel 2000)
3 Months	-76.17%	0.0%
6 Months	-71.38%	0.0%
1 Year	50.0%	0.0%
3 Years	-2.11%	-22.1%

Perspective Therapeutics Inc. Key Statistics

in dollars & INR

Previous Close	$3.72
Open	$3.74
Today's High	$3.84
Today's Low	$3.53
Market Capitalization	$202.8M
Today's Volume	$1.1M
52 Week High	$19.05
52 Week Low	$2.28
Revenue TTM	$1.6M
EBITDA	$-55.8M
Earnings Per Share (EPS)	$-1.33
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-27.02%

How to invest in Perspective Therapeutics Inc. from India?

It is very easy for Indian residents to invest directly in Perspective Therapeutics Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Perspective Therapeutics Inc. stock in both rupees (INR) and dollars (USD). Search for Perspective Therapeutics Inc. or CATX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Perspective Therapeutics Inc. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Perspective Therapeutics Inc. shares which would translate to 0.225 fractional shares of Perspective Therapeutics Inc. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Perspective Therapeutics Inc.

219.23%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Investment in Perspective Therapeutics Inc. from India has grown in the last 30 days as on Dec 8, 2024. 219.23% more purchase transactions for Perspective Therapeutics Inc. in the last 30 days versus the previous period.

392%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for Perspective Therapeutics Inc. on INDmoney from India has grown in the last 30 days as on Dec 8, 2024. 392% more investors are searching Perspective Therapeutics Inc. in the last 30 days versus the previous period.

Analyst Recommendation on Perspective Therapeutics Inc.

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Perspective Therapeutics Inc.(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Perspective Therapeutics Inc.

What analysts predicted

Upside of 436.35%

Current:

$3.76

Target:

$20.17

Insights on Perspective Therapeutics Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 1.90M → -5.23M (in $), with an average decrease of 374.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -24.67M → -11.70M (in $), with an average increase of 52.9% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 64.7% return, outperforming this stock by 15.9%

Perspective Therapeutics Inc. Technicals Summary

Sell

Neutral

Buy

Perspective Therapeutics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Perspective Therapeutics Inc. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Perspective Therapeutics Inc.	-66.93%	-71.38%	50.0%	-2.11%	-2.11%
Stryker Corporation	1.73%	9.85%	30.52%	46.79%	93.03%
Boston Scientific Corp.	2.58%	16.93%	63.83%	119.31%	105.7%
Edwards Lifesciences Corp.	9.36%	-15.88%	3.02%	-39.81%	-5.18%
Abbott Laboratories	-0.86%	7.54%	8.82%	-12.78%	36.7%
Medtronic Plc	-4.08%	1.2%	5.54%	-25.41%	-24.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Perspective Therapeutics Inc.	NA	NA	NA	-0.83	-0.27	-0.14	NA	4.86
Stryker Corporation	40.99	40.99	2.67	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.82	74.82	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.63	28.63	6.78	2.52	0.19	0.11	NA	16.18
Abbott Laboratories	35.24	35.24	2.25	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Perspective Therapeutics Inc.	Buy	$202.8M	-2.11%	NA	0.0%
Stryker Corporation	Buy	$145.8B	93.03%	40.99	16.34%
Boston Scientific Corp.	Buy	$133.9B	105.7%	74.82	11.26%
Edwards Lifesciences Corp.	Buy	$42.7B	-5.18%	28.63	65.86%
Abbott Laboratories	Buy	$201.1B	36.7%	35.24	13.99%
Medtronic Plc	Buy	$110.6B	-24.23%	26.38	12.06%

About Perspective Therapeutics Inc.

the introduction of cesium-131 represents the culmination of decades of work and millions of dollars of investment. top medical centers, hospitals and clinics across the united states are now offering this breakthrough treatment for cancer patients. the word brachytherapy derives from the greek prefix brachy, meaning “short” or “close,” because the titanium capsules containing the radioisotope are implanted directly into the cancerous prostate gland. treatment of cancer using low dose radiation or “seed” brachytherapy was pioneered in the 1960’s as an effective alternative to radical prostatectomy. pioneers in brachytherapy research initially theorized about the use of cesium-131 in a titanium capsule, however scientific and economic limitations at the time prevented its development and iodine-125 emerged as an alternative. beginning in 1967, iodine-125 became the first radioisotope manufactured in a titanium capsule, or seed. while its use continues to this day, many patients and doct

Organization	Perspective Therapeutics Inc.
Employees	116
CEO	Mr. Johan M. Spoor
Industry	Miscellaneous

Important FAQs about investing in Perspective Therapeutics Inc. from India :

What is Perspective Therapeutics Inc. share price today?

Perspective Therapeutics Inc. (CATX) share price today is $3.76.

Can Indians buy Perspective Therapeutics Inc. shares?

Yes, Indians can invest in the Perspective Therapeutics Inc. (CATX) from India.

With INDmoney, you can buy Perspective Therapeutics Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Perspective Therapeutics Inc. at zero transaction cost.

How can I buy Perspective Therapeutics Inc. shares from India?

It is very easy to buy Perspective Therapeutics Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Perspective Therapeutics Inc. be purchased?

Yes, you can buy fractional shares of Perspective Therapeutics Inc. with INDmoney app.

What are the documents required to start investing in Perspective Therapeutics Inc. stocks?

To start investing in Perspective Therapeutics Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Perspective Therapeutics Inc.

Today’s highest price of Perspective Therapeutics Inc. (CATX) is $3.84.

Today’s lowest price of Perspective Therapeutics Inc. (CATX) is $3.53.

What is today's market capitalisation of Perspective Therapeutics Inc.

Today's market capitalisation of Perspective Therapeutics Inc. CATX is 202.8M

What is the 52 Week High and Low Range of Perspective Therapeutics Inc.

52 Week High
$19.05
52 Week Low
$2.28

How much percentage Perspective Therapeutics Inc. is down from its 52 Week High?

Perspective Therapeutics Inc. (CATX) share price is $3.76. It is down by 99% from its 52 Week High price of $19.05.

How much percentage Perspective Therapeutics Inc. is up from its 52 Week low?

Perspective Therapeutics Inc. (CATX) share price is $3.76. It is up by 1% from its 52 Week Low price of $2.28.

What are the historical returns of Perspective Therapeutics Inc.?

1 Month Returns
-66.93%
3 Months Returns
-71.38%
1 Year Returns
50%
5 Years Returns
-2.11%

Who is the Chief Executive Officer (CEO) of Perspective Therapeutics Inc.

Mr. Johan M. Spoor is the current Chief Executive Officer (CEO) of Perspective Therapeutics Inc..

Discover More

Explore all